Indeed, the evidence presented in this study suggests the potential of M. charantia to reduce hyperglycaemia based on reduced FBG, insulin, HbA1c and HOMA-IR in individuals living with prediabetes and T2D. The gene discussed is INS; the disease is Hyperglycemia.